title: Combination treatment with a tumour necrosis factor antagonist and an oral retinoid: efficacy in severe acral psoriasis?
authors.forename: J R
authors.initials: JR
authors.lastname: Ingram
authors.forename: A V
authors.initials: AV
authors.lastname: Anstey
authors.forename: V
authors.initials: V
authors.lastname: Piguet
mesh_terms: D017255:Acitretin / Q000627:therapeutic use*; D000293:Adolescent; D000077556:Alitretinoin; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D003879:Dermatologic Agents / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D006801:Humans; D000069285:Infliximab; D008297:Male; D011565:Psoriasis / Q000188:drug therapy*; D012720:Severity of Illness Index; D016896:Treatment Outcome; D014212:Tretinoin / Q000627:therapeutic use*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
chemical_list: D000911:Antibodies, Monoclonal; D003879:Dermatologic Agents; D014409:Tumor Necrosis Factor-alpha; D000077556:Alitretinoin; D014212:Tretinoin; D000069285:Infliximab; D017255:Acitretin